Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib Cream in Mild to Moderate Alopecia Areata
NCT04445363Phase 2Active, not recruiting
- Sponsor
- Zelgen
- Start
- Aug 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in alopecia areata, sponsored by Zelgen. Started Aug 2020; status: active, not recruiting.
02
Drugs
jaktinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04445363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04445363.